4 stories mentioning HKG:3908
Every FINWIRES story that references HKG:3908, newest first.
China International Capital (HKG:3908, SHA:601995) conducted a review into Bio-Thera Solutions' (SHA:688177) proposed foreign exchange hedging activities, according to a Shanghai bourse filing on Friday.The financial services provider said it has no objection to the proposal, which is found that are intended to improve Bio-Thera's ability to manage foreign exchange risks.
China International Capital (HKG:3908, SHA:601995) posted profit attributable to shareholders of 3.58 billion yuan for the first quarter, up 75% from 2.04 billion yuan a year earlier, according to a Wednesday Hong Kong bourse filing.Hong Kong-listed shares of the investment bank were down 2% in Thursday afternoon trade.Earnings per share came in at 0.703 yuan, compared with 0.382 yuan a year earlier.Operating revenue rose 54% to 8.8 billion yuan from 5.7 billion yuan in the prior-year period.
Shandong Chunguang Technology Group (SHE:301531) launched its initial public offering on the Shenzhen bourse, seeking to offer up to 54.9 million shares, according to a prospectus filed Thursday.The magnetic materials and electronic information technology company's IPO shares will constitute 25% of the company's entire shareholding following the offer.Upon completion of the IPO, Chunguang's share capital will rise to 219.7 million shares.China International Capital Corp. (HKG:3908, SHA:601995) is the sponsor and lead underwriter of the offering.
China International Capital's (SHA:601995, HKG:3908) expects an attributable profit of between 3.37 billion yuan and 3.88 billion yuan in the first quarter of 2026, up 65% to 90% from 2.04 billion yuan a year prior, according to a Wednesday Hong Kong bourse filing.The firm attributed the forecast to seizing favorable opportunities, rising trading activity, steady development, and business development among other factors.